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Poly(ADP-ribosyl)ation is a very early cellular response to DNA damage. Poly(ADP-ribose) (PAR) accumulation is transient since PAR is
rapidly hydrolyzed by poly(ADP-ribose) glycohydrolase (PARG). PARG may play a prominent role in DNA damage response and repair by
removing PAR from modified proteins including PARP-1. Using living cells, we provide evidence that in response to DNA damage induced by γ-
irradiation the cytoplasmic 103 kDa PARG isoform translocates into the nucleus. We further observed that the nuclear GFP-hPARG110 enzyme
relocalizes to the cytoplasm in response to DNA damage. Using different GFP-PARG fusion proteins specific for the nuclear and cytoplasmic
forms, we demonstrate their dynamic distribution between cytoplasm and nucleoplasm and a high mobility of major PARG isoforms by
fluorescence recovery after photobleaching (FRAP). The dynamic relocation of all PARG isoforms presented in this report reveals a novel
biological mechanism by which PARG could be involved in DNA damage response.
© 2005 Elsevier B.V. All rights reserved.Keywords: Poly(ADP-ribose) glycohydrolase; Poly(ADP-ribose); FRAP; Nucleocytoplasmic shuttling; Subcellular localization; DNA damage1. Introduction
Poly(ADP-ribosyl)ation is a post-translational protein mod-
ification involved in DNA repair [1], apoptosis [2,3],
transcription [4,5] and chromosome stability [6]. The formation
of this unique biopolymer is catalyzed mainly by the nuclear
enzymes poly(ADP-ribose) polymerase 1 (PARP-1) [7] and 2
(PARP-2) [8,9] but some catalysis also occurs through less
abundant PARPs family members (for a review see [10]). Upon
binding to DNA breaks, PARP-1 and PARP-2 are selectively
activated and within seconds synthesize large amounts of a
highly negatively charged PAR lattice on a variety of nuclear
proteins including themselves [7]. The removal of PAR from the
modified proteins is catalyzed by an enzyme, the poly(ADP-
ribose) glycohydrolase (PARG), which is encoded by a single⁎ Corresponding author. Tel.: +1 418 654 2267; fax: +1 418 654 2159.
E-mail address: guy.poirier@crchul.ulaval.ca (G.G. Poirier).
0167-4889/$ - see front matter © 2005 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbamcr.2005.11.015gene [11]. PARG possesses an exo- and endoglycosidase
activity that rapidly hydrolyzes PAR.
The PARG gene and structure/function relationships have
been recently characterized in different species [12–19]. It has
been demonstrated that the gene encoding human PARG is
alternatively spliced to generate three different protein isoforms
with molecular weights of, respectively, 110, 103 and 99 kDa
[18]. Expression of those multiple PARG isoforms has been
positively confirmed in different human and mouse cell lines
[14,18,20,21]. While some authors have shown the presence of
a full-length 110 kDa PARG gene product in mammalian cells
[14,18], only a limited number of studies have presented
significant biological data or biochemistry describing the full-
length 110 kDa human PARG. Previous studies have shown that
the overexpressed full length PARG110 localizes predominant-
ly to the nucleus [18,22], while PARG103 and PARG99
isoforms are cytoplasmic [18,23]. Interestingly, the cytoplasmic
PARG103 isoform accounts for nearly 90% of the entire cellular
activity [23]. The PARG enzyme contains a C-terminal catalytic
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which would be involved in protein–protein interactions [24].
Furthermore, our group has completed the proteomic charac-
terization of PARG-interacting proteins and found that
PARG103 and 110 are component of a multi-protein complex
involved in mRNA processing [25]. Moreover, a recent report
demonstrated that the amino acid residues 10CTKRPRW16
encoded by exon 1 of human PARG comprise a functional
nuclear localization signal (NLS) that targets PARG to the
nucleus [18], while other alternative NLS motifs have also been
reported in the C-terminal catalytic domain (Fig. 1A) [16].
Importantly, all PARG isoforms, like PARP-1, has been found
to be efficiently cleaved by caspase-3 in human cellsFig. 1. Dynamic of 103 kDa PARG during radiation-induced DNA damage. (A) Sch
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PAR can increase by 10- to 500-fold [28,30,31] in a fashion that
is directly proportional to the number of DNA strand breaks
[32,33]. Furthermore, it has been recently reported that during
DNA damage, the increased PAR synthesis leads to caspase-
independent cell death [3,34] supporting the hypothesis that
PAR turnover is essential for cell survival. Accordingly, recent
knockout models of PARG in Drosophila [35] and mice
[20,36,37] revealed that deletion or knockout of the PARG gene
results in hypersensitivity to DNA damage-induced cell death
and causes profound neurodegeneration. Thus, it is extremely
important that both cytoplasmic and nuclear levels of ADP-
ribose polymers are tightly controlled in order to prevent PARP-
1-induced cell death [11,38,39]. Therefore, it is not surprising
that PARG activity has been found to be critical for the
prevention of PARP-1 dependent cell death by regulating the
intracellular levels of PAR [38,40].
In this paper, we examined the spatiotemporal regulation
and dynamics of PARG during radiation-induced DNA
damage. Since most of the PAR synthesis following DNA
damage occurs in the nucleus and most of the PARG103
isoform, which is more abundant, is in the cytoplasm, we
performed experiments to determine whether or not the
cytoplasmic PARG103 translocates to the nucleus during or
after radiation-induced DNA damage. Using fluorescence
recovery after photobleaching (FRAP), we have characterized
the intracellular binding and diffusion kinetics of two major
PARG isoforms, 103 and 110 kDa, and determined their
cellular distribution. We present direct evidence that the
PARG110 relocalizes to the cytoplasm during γ-irradiation
while cytoplasmic PARG103 and the apoptotic fragments can
access to the nucleus.
2. Materials and methods
2.1. Plasmid constructs and mutagenesis
Expression plasmids encoding for green fluorescent protein (GFP) fused
with either the 103 kDa bovine PARG isoform (GFP-bPARG-103), the 85 kDa
or 74 kDa apoptotic fragments (GFP-bPARG-85, GFP-bPARG-74) were
produced according to Bonicalzi et al. [23]. In addition, an expression construct
of the full-length 110 kDa human PARG was obtained by cloning a 3.0-kbp
EcoRI–SalI polymerase chain reaction fragment, amplified from hPARG cDNA
(ATCC Image Clone 606-4831) with the following primers pairs: hPARG
forward (5′-GGCGAATTCCATGAATGCGGGCCCCGGCT-3′) and reverse
(5′-ACGCGTCGACTCAGGTCCCTGTCCTTTGCC-3′), in frame to the 5′
end of the pEGFP-C1 expression vector (Clontech). After transfection, this
construct generates a fusion protein (GFP-hPARG-110) with GFP at the N-
terminal end and hPARG at C-terminal end (Fig. 1A). N-terminal GFP fusion
proteins have been selected to produce a fully active PARG construct, which
could not be obtained when GFP is fused to the C-terminal active domain. Site-
directed mutagenesis has been done on this plasmid to change the aspartic acid
by alanine (D→A) into the two caspase cleavage sites in order to produce an
uncleavable hPARG-110 construct. This mutagenesis was generated with
QuickChange™ XL site-directed mutagenesis kit (Stratagene) with primers
pairs: hPARGD253A forward (5′-GCAAGTTGTCAGCAAGCTGAGATAGA-
TAGATGTGGTGCC-3′) and reverse (5′-GGCACCACATCTATCTCAGC-
TATCTCAGCTTGCTGACAACTTGC-3) to mutate the 253DEID256 site in
AEID. The mutation of 304MDVD307 site in MDVA was performed using the
primers pairs: hPARGD307A forward (5′-CCCGAGTCACCGATGGATGTGGC-
TAATCTAAAAATAG-3′) and reverse (5′-CTATTTTTAGAATTAGCCA-CATCCATCGGTGACTCGG-3′). The following plasmids were obtained after
mutagenesis: GFP-hPARG-110AEID and GFP-hPARG-110AEID/MDVA. All con-
structs sequences were verified by automated DNA sequencing.
2.2. Cell culture, transfection, and ionizing radiation conditions
Human neuroblastoma SK-N-SH cells obtained from the American Type
Culture Collection were grown in Dulbecco's modified Eagle's medium
(DMEM) supplemented with 10% fetal bovine serum (FBS), penicillin (100 U/
ml) and streptomycin (100 μg/ml). Cells were maintained at 37 °C, under a 5%
CO2 controlled atmosphere in a humidified incubator. For expression of all
GFP-fusion proteins, SK-N-SH cells were grown either on coverslips or in 10-
cm-diameter culture dish at 60% confluence and transiently transfected with
Effecten reagent (Qiagen) according to the manufacturer's protocols. Cells were
exposed to a dose of 2 or 5 Gy with a Gammacell-40 γ-ray irradiator (Nordion)
depending of experimental procedures. Controls were run in parallel without γ-
irradiation. We used molecular markers characteristic of cells bearing DNA
double-strand breaks. These markers include nuclear foci of phosphorylated
ATM kinase and PAR synthesis.
2.3. Indirect immunofluorescence staining
Transiently transfected cells were fixed 24 h post-transfection with 4.0%
paraformaldehyde in phosphate-buffered saline (PBS) (pH 7.5) for 15 min at
room temperature. Cells were stained with an appropriate primary antibody
diluted in 45-μl aliquots of PBS containing 10% FBS and 1% Triton X-100 for 1
h at room temperature. Coverslips were rinsed with PBS containing 10% FBS
and 1% Triton X-100 and washed twice with PBS prior to a 30-min incubation
with an appropriate secondary antibody conjugated to a fluorophore. Finally,
paraformaldehyde-fixed cells were counterstained with Hoechst 33342 to stain
DNA. PAR synthesis was visualized with the rabbit anti-PAR 96-10 antibody and
an anti-rabbit Texas-Red conjugated secondary antibody (Jackson Laboratory).
Phosphorylation of ATM protein kinase was visualized with a phospho-ATM
(Ser1981) (clone 10H11.E12) mouse monoclonal antibody (Cell Signalling) and
an anti-mouse Alexa-Fluor 488 secondary antibody (Molecular Probes).
2.4. Fluorescence microscopy analysis
Coverslips labelled as described above were mounted in polyvinyl alcohol
(PVA) medium containing antifading agents, sealed and placed on a Nikon
TE2000E inverted microscope equipped with an oil immersion 100×1.40 N.A.
objective and a Hamamatsu Orca ERS deep cooled CCD camera. For
determination of PARG localization, multiple fields were examined to count
at least 200 cells. Z-series extending above and below individual nuclei were
collected at 500-nm intervals. Images were acquired under identical conditions,
ensuring that the maximal signal was not saturated. Images were processed by
constrained iterative deconvolution procedure in Priism/IVE 4.0 software [41]
by using the enhanced ratio method. Deconvolved images were visualized in
Imaris 4.0 (Bitplane). Image brightness/contrast and baseline subtraction were
adjusted using Imaris 4.0 (Bitplane) and the measurement of fluorescence
intensity and colocalization was performed using MetaMorph 6.0 (Universal
Imaging) software. Composite figures of collected images were assembled in
Adobe Photoshop.
2.5. Fluorescence recovery after photobleaching (FRAP)
During FRAP experiments, a defined area of a living cell is bleached
irreversibly by a high-energy laser pulse. The recovery of the fluorescence signal
in the bleached area corresponds to movement of the GFP-fusion protein and is
monitored in real-time with low-intensity scanning laser light (0.1%). FRAP
analysis was carried out with living SK-N-SH cells grown on coverslips. Cells
were transfected with various GFP fusion proteins and mounted on an incubation
chamber filled with medium 24 h after transfection. A laser-scanning confocal
(Zeiss LSM510) equippedwith a 488-nm laser light and a 40×1.3N.A. objective
was used to perform all photobleaching experiments. Fluorescence recovery was
monitored over a 16 s period for fast recovery and 30 s for nucleolar recovery. For
data analysis, normalization was performed to account for the initial
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collection of the individual time points. In the normalized data set presented,
100% recovery represents the theoretical value that the photobleached regions
will attain after accounting for the amount of fluorescence lost during the original
photobleaching. Details of data normalization have been presented elsewhere
[42,43]. Differential interference contrast (DIC) images were also collected to
ensure that cells were viable.
2.6. PARG activity gels
Wild-type and transfected SK-N-SH cells were scraped in PBS containing
complete protease inhibitor cocktail (Roche Molecular Biochemicals) and an
equal volume of 2× sample buffer (100 mM Tris–HCl pH 6.8, 4% SDS, 20%
glycerol, 10% β-mercaptoethanol, 0.2% bromophenol blue) supplemented with
protease inhibitor cocktail prior to sonication. Samples were neither heated nor
frozen before loading. Activity gels were immediately performed as described by
Brochu et al. using 32P-automodified PARP-1 as a source of poly(ADP-ribose)
[44].
2.7. Subcellular fractionation, SDS-PAGE and western blot analysis
Cellular fractionation was carried out essentially as described by Chi and
Lodish [45] and subcellular fractionation was accomplished by differential
centrifugation [46]. Cells were resuspended in an hypo-osmotic solution
containing 10 mM Tris–HCl pH 7.4, 10 mM NaCl, 1.5 mM MgCl2, 0.1%
Triton X-100, 1 mM dithiothreitol, 0.5 mM phenylmethyl sulfonyl fluoride and
complete protease inhibitor cocktail. Cells were kept on ice for 15 min and then
homogenized in a tight-fitting Dounce homogenizer. Prior to centrifugation,
sucrose was added to the homogenate to obtain a final concentration of 250 mM
(using a solution containing 2.5 M sucrose, 50 mM Tris–HCl pH 7.4 and 10 mM
EDTA) before addition of 140 mM KCl. Whole cell extract (WCE) was
centrifuged at 1000×g for 10min to recover nuclei (P1). The supernatant (S1)was
clarified at 15,000×g for 10 min. The P15 pellet was kept and designed to be the
mitochondria-enriched fraction. The supernatant (S15) obtained was again
centrifuged at 100,000×g for 60 min. The supernatant (S100) was used as
cytosolic fraction. Pellets (P1 and P15) were resuspended in a solution containing
250mMsucrose, 10mMTris–HCl pH7.4, 0.5mMEDTA and complete protease
inhibitor cocktail. Protein concentration was determined by the Bradford assay
(BioRad). Proteins were separated in 4–12% linear gradient SDS-PAGE and then
electroblotted onto a 0.2 μm nitrocellulose membrane (BioRad). The membranes
were probed with anti-GFP (Clonetech), anti-PARP-1 (clone C2-10), anti-PAR
96-10 and anti-actin antibody, followed by the appropriate secondary antibody.
Immunoblots were visualized by enhanced chemiluminescence (ECL plus
reagent; PerkinElmer) and exposure to X-ray film (Kodak).
2.8. PARG activity assays
PARG activity was measured essentially as described by Jonsson et al. [47].
The different subcellular fractions were prepared as described above. The
reaction mixture for the assay contained 50 mM potassium phosphate pH 7.5, 50
mMKCl, 100 μg/ml bovine serum albumin, 10 mMβ-mercaptoethanol, 0.1 mM
PMSF, 10μM [32P]-labelled PAR. The reaction was started by the addition of the
cell extracts and stopped after 10 min by the addition of SDS at a 0.1% final
concentration. An aliquot of each reaction was applied on polyethyleneimine-
cellulose TLC plate. The plate was first developed at room temperature in
methanol, dried, and then developed in 0.3 M LiCl, 0.9 N acetic acid. The TLC
plate was electronically autoradiographed on Instant Image Analyzer (Packard
Instrument Company) to determine the amount of radioactivity in each spot. The
amounts of radioactivity found in the ADP-ribose spot and the origin were used
to calculate PARG-specific activity. One unit of PARG is defined as the amount
of enzyme required to release 1 nmol of ADP-ribose per min at 37 °C under assay
conditions.
2.9. Data analysis
Fluorescence recovery values were exported to Microsoft Excel to calculate
the FRAP curves with correction for total fluorescence loss. These correctedvalues were copied to SigmaPlot 8.0 software (SYSTAT Software Inc.) for non-
linear regression analysis using the single exponential association curve fitting
equation with b95% confidence. All values are expressed as mean±S.E.M.
Statistical significance of difference between two groups was tested using
Student t-test. P values less than 0.05 were considered to be significant. When
data sets were compared, identical conditions were used in photobleaching
experiments including the number of cells, the area of the photobleach region
and the time course of imaging at low laser power (0.1%).
3. Results
3.1. Dynamics of the cytoplasmic PARG103 isoform
We first investigated the cellular distribution of major 103
kDa bovine PARG isoform (bPARG103) during radiation-
induced DNA damage using GFP fusion protein and live cell
imaging. It is now well accepted that PARG103 enzyme is
cytoplasmic [18,23] and represents the most abundant PARG
form in both quantity and activity. To study the distribution of
PARG103, we used transiently transfected human SK-N-SH
neuroblastoma cell line with GFP-bPARG103 24 h prior to γ-
irradiation. The construction of an N-terminal fusion of PARG
with enhanced GFP used for FRAP analysis in living cells is an
elegant approach since it allows the expression of a fully active
enzyme, which was not obtained when the GFP is fused to the
C-terminal catalytic domain. We first established that the
different GFP-PARG fusion proteins behave like their wild type
counterparts in terms of activity and cellular localization.
Although the fusion protein behaves like its endogenous
counterpart, we cannot rule out that there is a modest reduction
in the binding affinity of the eGFP tagged PARG. Accordingly,
we validated that GFP-bPARG103 is distributed mostly in the
cytoplasm of untreated neuroblastoma cells. In addition, we
observed that the GFP-bPARG103 translocates into the nucleus
in the presence of ionizing radiation (Figs. 1B–C). This is, to
our knowledge, the first instance where nuclear translocation of
the PARG103 is observed in living cells after DNA damage
induction, although it has previously been shown that GFP-
bPARG103 would accumulate into the nucleus following
leptomycin B treatment [23]. Fluorescence microscopy analysis
reveals that all four transfected cells shown in Fig. 1C exhibit a
lower PAR accumulation compared to untransfected ones. This
is consistent with previously reported overexpression experi-
ments which suggest that the transition of bPARG103 isoform
from cytoplasm to nucleus might regulate PAR catabolism
[11,23].
We next analyzed whether γ-irradiation affects the kinetics
of PARG103 in various cellular compartments. Accordingly, we
performed FRAP experiments on cells overexpressing GFP-
bPARG103. We thus irreversibly bleached the fluorescence of
GFP-bPARG103 in a small region of the nucleus or cytoplasm
and subsequently recorded the recovery of fluorescence over a
period of 16 s [43]. The kinetics of recovery was measured at
specific time points (1, 4 and 24 h) following γ-irradiation and
corresponds to the mobility of the labelled GFP-PARG103
proteins within the cell compartments. Using this approach, we
observed differences in the recovery after photobleaching
between the nuclear and cytoplasmic sub-populations (Fig. 2).
Fig. 2. Fluorescence recovery after photobleaching analyses of nuclear and cytoplasmic GFP-bPARG103 isoform. Transiently expressed GFP-bPARG103 constructs
in live SK-N-SH cells were subjected to quantitative FRAP analysis. (A) The upper panel shows the time-lapse images collection of GFP-bPARG103 recovery after
photobleaching in untreated cells. The bottom panel shows FRAP images of GFP-bPARG103 expressing cell 4 h after irradiation (2 Gy). Time in seconds is shown at
the top of each panel. The nuclear and cytoplasmic region where FRAP was performed is indicated by arrows. (B–C) For quantitative analysis, fluorescence recovery
in the bleached area and intensities in different cytoplasmic and nuclear regions as well as the background signal were quantified with minimal laser power. Data
obtained for recovery were corrected for the background intensity and loss of total fluorescence. The insert presents data obtained from fluorescence recovery of GFP
control experiments. The plot shows normalized mean values of fluorescence intensity versus time in seconds after photobleaching. The mobility of GFP-bPARG103
in cytoplasmic and nuclear compartments was compared (B) before and (C) 4 h after γ-irradiation (2 Gy). P values calculated using the Student's t test indicate the
significance of the difference in recovery time between nuclear and cytoplasmic pool of GFP-bPARG103.
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protein is significantly faster than it was in the cytoplasm. In
undamaged cells, nuclear and cytoplasmic fluorescence recov-
ery of GFP-bPARG103 was completed in 7.12 s and 12.12 s,
respectively. Despite being catalytically active, γ-irradiation
does not affect the recovery time of either nuclear or
cytoplasmic population of PARG103 (Figs. 2B–C). Accord-
ingly, we noticed that 4 h following γ-irradiation the
fluorescence recovery of nuclear and cytoplasmic GFP-
bPARG103 was completed in 7.65 s and 11.65 s, respectively.
3.2. Nuclear to cytoplasm translocation of PARG110 following
genotoxic stress
To further investigate the nuclear localization of full-length
PARG, we used cells transfected with GFP-hPARG110 vector
and performed biochemical measurements. First, we demon-
strate that the level of poly(ADP-ribosyl)ation in neuroblastoma
cells overexpressing GFP-hPARG110 was significantly reduced
following γ-irradiation relative to control cells, consistent with
an enzymatically active GFP-hPARG110 in transfected cells
(Figs. 3A–B). Additionally, the majority of endogenous PARG
activity was found in the cytoplasm, whereas cells over-
expressing GFP-hPARG110 have an increased nuclear PARGactivity (Fig. 3C). Other groups also report that the PARG
cytoplasmic isoforms predominate within cells [18,22,23].
Using fluorescence microscopy, we confirm the previously
observed nuclear localization of the GFP-tagged full-length
human PARG110 in untreated mammalian cells (Fig. 4)
[18,22,25]. Somewhat unexpectedly, fluorescence microscopy
analysis revealed that the subcellular distribution of GFP-
hPARG110 changes dramatically during γ-irradiation. We
observed that the GFP-hPARG110 relocalizes to the cytoplasm
as rapidly as 1 h after induction of DNA damage by γ-
irradiation (Fig. 4). Likewise, it has been reported previously
that during mitosis most of the GFP-hPARG110 protein does
not associate with chromosomes [22]. We ascertain that the 5
Gy dose of γ-irradiation used in our experiments induces
significant DNA double-strand breaks and results in massive
PAR synthesis (Fig. 5A). Thereafter, we used an activity gel to
visualize the full-length GFP-hPARG110 protein activity before
and after DNA damage induction; the GFP-hPARG110 was
detected at ~140 kDa (Fig. 5B).
To ensure that this nuclear to cytoplasmic relocation is
achieved by the full-length GFP-tagged hPARG110 and does
not represent the behaviour of caspase-3 cleaved GFP-
fragment, we engineered constructs where the two caspase
cleavage sites DEID and MDVD were mutated to uncleavable
Fig. 3. Activity of endogenous and GFP-hPARG110 expressing neuroblastoma cells. SK-N-SH cells were treated with γ-irradiation (5 Gy) or left untreated. Total
extracts from (A) wild-type and (B) GFP-hPARG110 expressing cells were prepared and immunoblotted with anti-PAR antibodies. Actin blot were shown as a loading
control. PAR stimulation is less abundant in cells overexpressing hPARG110. (C) Histogram displaying PARG-specific activity in different subcellular fractions of
wild-type cells and GFP-PARG110 overexpressing cells. SK-N-SH cells were fractionated by differential centrifugation as described in Materials and methods. Extract
from whole cell extract (WCE), pellets (P1, P15) and supernatant (S100) were analysed for PARG using the TLC assay. Data from a representative experiment is
shown.
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the hPARG110AEID/MDVA could not be cleaved by caspase-3
following DNA damage, whereas the wild-type GFP-
hPARG110 as well as PARP-1 were effectively cleaved
after this genotoxic stress (Figs. 5C–E). According to the
PARG activity gel presented in Fig. 5B, none of the GFP-
PARG110 constructs was cleaved by caspase-3 before or 1
h after radiation-induced DNA damage. We show that the two
uncleavable GFP-hPARG110 constructs translocate from the
nucleus to the cytoplasm in a manner that is quantitatively
indistinguishable from wild-type hPARG110 (Fig. 4).
3.3. Nuclear PARG110 associates with nucleoli
When we examined the nuclear fluorescence pattern of GFP-
hPARG110 in living cells, we observed a slight enrichmentwithin the nucleolus (Fig. 6). To confirm that this localization
overlapped with known nucleolar proteins, we co-transfected
SK-N-SH neuroblastoma cells expressing GFP-hPARG110
with a nucleolin-DsRed vector. When we compared the
nucleolin-DsRed and GFP-hPARG110 we found that a sub-
population of nuclear hPARG110 colocalizes with nucleolin in
vivo (Fig. 6A). Based on our observation of the nucleolar
accumulation of GFP-hPARG110, we wanted to investigate
whether this nucleolar pool is in a dynamic equilibrium with
GFP-hPARG110 in the nucleoplasm. FRAP experiments show
that GFP-hPARG110 can return into a bleached area defining
the nucleolus (Fig. 6B) and the nucleolar pool of GFP-
hPARG110 was replenished in about 22 s. Thus, hPARG110
is dynamically associated with nucleolar components. This
result is consistent with the recent observation that GFP-
hPARG110 binds to nucleolar proteins [25]. Surprisingly,
Fig. 4. Nuclear to cytoplasmic translocation of 110 kDa PARG after DNA damage. SK-N-SH cells were transiently transfected with the fusion constructs and
moderately expressing cells were left untreated or irradiated with γ-ray (5 Gy). Following a 1-h recovery period under optimal conditions, cells were fixed with 4%
formaldehyde and GFP-hPARG110 cellular localization was observed by fluorescence microscopy. DNAwas counterstained with Hoechst 33342. Z-series extending
above and below individual nuclei were collected at 500-nm intervals. Selected focal plan from deconvolution images are presented for GFP fluorescence (green)
along with nuclear DNA staining (blue). For the determination of GFP-hPARG110 localization after DNA damage, multiple fields were examined to count at least 200
cells for each constructs. GFP-fusion proteins are indicated on the right. 
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fragments when located in the nucleus (Figs. 7B and C).
3.4. Localization and regulation of PARG apoptotic fragments
during radiation-induced DNA damage
In previous studies, Affar and coworkers found that all forms
of endogenous PARG (110, 103 and 99 kDa) were cleaved in
human cells during DNA damage-induced apoptosis [21].
Caspase cleavage sites were identified at amino acid position
256 (DEID) and 307 (MDVD) of the human PARG sequence. It
was further demonstrated that PARG cleavage by caspase-3
generated two C-terminal fragments of 85 and 74 kDa that
retained full PARG enzymatic activity [21,23]. Because the two
apoptotic fragments remain active, it was important to define
their cellular distribution and dynamics in order to better
understand their relative roles. To determine whether or not
PARG85 and PARG74 apoptotic fragments are regulated
differently, SK-N-SH neuroblastoma cells were transiently
transfected with GFP-bPARG85 or GFP-bPARG74 and, after
allowing time for expression, time-lapse microscopy and
photobleaching studies were examined over a 24-h period. Inuntreated cells, all GFP-fusion proteins colocalized with their
endogenous counterparts (Fig. 7 and [23]). Moreover, we
noticed that a larger number of cells expressing GFP-bPARG85
or 74 exhibited nearly equal distribution of GFP fluorescence
throughout the cell at 4 and 24 h after γ-irradiation (Fig. 7). The
time lapse fluorescence microscopy observations reflect the
steady-state equilibrium of the nuclear import and nuclear
export processes and show that all PARG isoforms, including
apoptotic fragments, are in continuous flux between cytoplasm
and nucleus. Upon stimulation by γ-irradiation, we observed
that the apoptotic fragments PARG85 and PARG74 also
translocate from the cytoplasm into the nucleus of living cells.
Four hours after DNA damage induction, we observed a nuclear
fluorescence from GFP-bPARG85 and 74 overexpressing cells
similar to what we observed in cells overexpressing GFP-
bPARG103 (Fig. 7). This implies that nuclear accumulation of
the apoptotic fragments following radiation-induced DNA
damage could also play a prominent role in regulation of PAR
catabolism.
This information allowed us to follow the behaviour of GFP-
tagged apoptotic fragments by FRAP analysis following γ-
irradiation. Although the subcellular distribution was altered,
Fig. 5. Irradiation activates early PAR synthesis followed by late hPARG110 and PARP-1 cleavage. (A) SK-N-SK cells were irradiated (5 Gy), fixed and analysed by
indirect immunofluorescence microscopy using anti-PAR 96-10 antibodies (right panel) and anti-phospo-ATM ser 1981 antibodies (left panel). DNAwas stained with
Hoechst 33342. Irradiation rapidly stimulates PAR synthesis and ATM Ser-1981 phosphorylation in neuroblastoma cells. (B) PARG activity gel of SK-N-SH cells
following treatment with γ-irradiation (5 Gy). Lysates of untransfected SK-N-SH cells or cells expressing GFP-hPARG110 and each of the 2 uncleavable mutated
proteins were prepared and enzymatic activity was detected by performing activity gel as describe in Materials and methods. GFP-hPARG110 construct are active
before and after DNA damage induction and they were not cleaved at 1 h after irradiation. SK-N-SH cells expressing either (C) GFP-hPARG110 or (D) GFP-
hPARGAEID/MDVAwere treated with γ-irradiation (5 Gy) or left untreated. Total extracts were prepared and immunoblotted with anti-GFP antibodies and anti-actin. (E)
Total extracts prepared from wild-type neuroblastoma cells and immunoblotted with anti-PARP-1 and anti-actin antibodies. PARP-1 cleavage was used as indicator of
apoptosis induction. GFP-hPARG110 is efficiently cleaved as well as PARP-1 in radiation induced DNA damage. The uncleavable mutant remains intact under the
same conditions.
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bPARG103 and the apoptotic fragments (Supplementary Fig.
S1). As we presented for GFP-bPARG103, the fluorescence
recovery of both GFP-bPARG85 and 74 was complete by
approximately 8 s for nuclear population and 12 s for
cytoplasmic pool. Taken together, these results indicate that
caspase-3 cleavage of PARG does not affect either the activity
or mobility of PARG. Therefore, there is no evidence that, once
generated, the apoptotic fragments are not participating in PAR
metabolism.
4. Discussion
The synthesis and rapid turnover of ADP-ribose polymers is
an immediate cellular response to DNA damage [7], but, in
contrast to the well-characterized role of PARP-1, the behaviour
of PARG in the response to DNA damage has not been
extensively studied. In this report, we employed live cell
imaging to define the dynamic localization and relocation of
two major PARG isoforms, 103 and 110 kDa, following
radiation-induced DNA damage. Earlier studies using immu-
nocytochemistry or expression of GFP-fused PARG havepreviously revealed nuclear accumulation upon leptomycin B
treatment [23] and the steady-state distribution of PARG
between nucleus and cytoplasm [18,22,23,48]. These properties
are dictated by the relative rates of nuclear import and export.
Our results reveal that the subcellular distribution of PARG is
more dynamic than previously thought.
In this study, we demonstrate that even though GFP-
bPARG103 is predominantly localized in the cytoplasm in
absence of genotoxic stress, it rapidly shuttles between the
cytoplasm and the nucleus following DNA damage. It is
important to note that even if PARG103 lacks the entire exon 1
encoded NLS motif, it was still able to be imported into the
nucleus when DNA damage is present. We cannot exclude that
the putative NLS identified in C-terminal catalytic domain (Fig.
1A) could account for its nuclear localization or that nuclear
import could be mediated by a binding partner [11,23]. In
addition to the remarkable change in localization (Figs. 1B–C),
we examined whether the induction of DNA damage by γ-
irradiation altered the mobility of GFP-bPARG103 within either
compartment. This issue is important because such a change
would be a reflection of a change in the protein–protein or
enzyme–substrate interactions of PARG following genotoxic
Fig. 6. Nuclear 110 kDa full-length PARG can be associated with nucleoli. (A) SK-N-SH cells cotransfected with nucleolin-DsRed and GFP-hPARG110 were imaged
24 h after transfection. Fluorescent images were captured in living cells overexpressing both construct. The overlay of GFP-hPARG110 fluorescence and the nucleolin-
DsRed shows colocalization of these proteins in nucleoli. (B) Live-cell fluorescent patterns of cells transfected with GFP-hPARG110 alone. The nucleolar structures
are indicated by arrows. (C) Transiently transfected SK-N-SH cells expressing GFP-hPARG110 were bleached in a small area of an entire nucleolus (indicated by an
arrow) and nucleolar import then visualized over 30 s by low intensity laser-scanning multi-photon microscopy to assess the return of fluorescence. Recovery of GFP-
hPARG110 in nucleolus is seen in less than 22 s.
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neuroblastoma to study the mechanism responsible for the
change in GFP-bPARG103 subcellular distribution. An under-
lying feature is that PARG displays very fast kinetics and has a
transient localization in the nucleus. Because the GFP-PARG
fusion proteins used in our experiments retain the capacity to
degrade PAR polymers, our results imply that the GFP-
bPARG103 has the potential to rapidly reach sites of massive
PAR synthesis that are triggered by signals elicited after DNA
damage (Fig. 1C). Another important conclusion is that the
nuclear fluorescence recovery time of the PARG103 isoform is
within the same range as PAR turnover observed after DNA
damage [30,49]; both of them are completed in less than 30 s.
However, we found that the kinetics of GFP-bPARG103 is
not significantly influenced by genotoxic stress, supporting the
hypothesis that the nucleocytoplasmic shuttling dynamics,
rather than protein–protein interactions, is altered by DNA
damage. Consequently, this alteration of the nucleocytoplasmic
shuttling dynamics is expected to change the relative amount of
enzymatically active PARG103 isoform between the nuclear
and cytoplasmic compartments. We also found that the recovery
of GFP alone was significantly faster than fusion proteins
independently of their cellular distribution (Fig. 2B, insert).Although the mobility of fusion proteins is significantly lower
than GFP alone (Fig. 2B), we found that protein immobilization
is not responsible for the retention of PARG103 in the
cytoplasm since PARG can diffuse throughout intracellular
compartments. None of the results presented here support a
hypothesis that PARG103 is restricted to or tightly associated
with an organelle. Rather, the results on GFP-bPARG103
revealed rapid recovery that is consistent with a soluble enzyme
undergoing very transient reversible binding to very large
macromolecules of cellular structures. Therefore, we propose
that the regulated cytoplasmic and nuclear trafficking plays a
critical role in determining the overall distribution of PARG103
isoform in untreated cells and upon radiation-induced DNA
damage. The pathway involved in the transport of PARG is
mostly unknown, but we speculate that γ-irradiation trigger a
change from a tight and controlled nucleocytoplasmic shuttling
to a leakier nuclear envelope allowing rapid exchange of PARG
between the two compartments. Clearly, more work is required
to elucidate the molecular mechanisms that regulate the
equilibrium between nuclear import and nuclear export
following γ-irradiation.
Consistent with a potential role at an early step of radiation-
induced damage [50], we demonstrate that, following γ-
Fig. 7. Cellular localization of the 103 kDa PARG and the two apoptotic
fragments following radiation-induced DNA damage. Fluorescence microscope
images of living SK-N-SH cells transiently transfected with GFP-bPARG103
isoform (A), as well as apoptotic fragments GFP-bPARG85 (B), and GFP-
bPARG74 (C). DNA damage were induced in SK-N-SH with γ-irradiation at a
2-Gy dose and imaged at specific time points by multi-photon fluorescence
microscopy. DIC images were also collected to monitor cell viability. We
observe more than 100 cells for each condition and representative images were
shown. The regulation of subcellular localization following radiation-induced
DNA damage was the same for these three isoforms.
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(Fig. 4). We used several uncleavable hPARG constructs to
ensure that the fluorescence of GFP-hPARG110 would reflect,
as closely as possible, the cellular distribution of the full-length
hPARG110 rather than the caspase-3 cleavage products. Thus,
we verified that relocation of hPARG110 following γ-irradiation
is not the result of caspase-3 cleavage since the uncleavable
mutants redistribute in a manner identical to hPARG110 (Fig. 4).Collectively, our findings support the hypothesis that under
conditions of genotoxic stress, the translocation of nuclear
hPARG110 to cytoplasm promotes nuclear PAR accumulation.
Consistent with this notion is the observation that N-methyl-N′-
nitro-N-nitrosoguanidine (MNNG) treatment resulted in a
decrease of nuclear PARG activity [18]. Our results provide
the first evidence that the transient decrease in PARG activity
can be determined by nucleocytoplasmic translocation of
PARG110 isoform and is not simply the result of caspase 3-
mediated cleavage. This remarkable observation provides in
vivo evidence that PARG subcellular distribution may be used to
maintain an appropriate PAR threshold under normal and
pathological conditions.
We have shown that the majority of hPARG110 is located in
the nucleoplasm of undamaged neuroblastoma SK-N-SH cells
(Fig. 4), and that the enzyme also enriches in the nucleolus (Fig.
6). Interestingly, a significant subnuclear population of PARP-1
and PARP-2 is also located in the nucleolus [51] and a recent
proteomics analysis of the human nucleolus confirmed the
nucleolar localization of PARP-1 [52]. The interdependency
between nucleolar accumulation of PARPs and poly(ADP-
ribosyl)ation of nucleolar proteins has been described in the past
[53,54]. Indeed, it has been shown that PAR synthesis induced
by alkylating agents is less efficient in the nucleolus than in the
nucleoplasm [51]. Thus, our observation that the association of
hPARG110 with the nucleolar region might involve the
sequestration of the active enzyme would explain the lower
steady-state level of poly(ADP-ribosyl)ation previously ob-
served in nucleolus. Although we have identified interactions
between PARG and other nucleolar proteins [25], we cannot
completely exclude the possibility that the hPARG110 accu-
mulation in the nucleolus is the result of an interaction with
either PARP-1 or PARP-2. Consequently, the regulation of
nucleolar localization of PARG110 by protein–protein interac-
tions is a tempting hypothesis given that nucleolar PARG has
been demonstrated to be a member of a ribonucleoprotein
complex [25]. In that case, the nucleolar accumulation of GFP-
PARG110 can be explained by a longer retention time of
individual GFP-PARG110 complexes in these structures or by a
higher concentration of interacting proteins or a combination of
both.
Because PARG is cleaved by caspase 3 into catalytically
active C-terminal fragments, it was important in our study to
define the properties of these isoforms as well. In particular, we
wanted to determine whether or not the PARG apoptotic
fragments will respond to a damage-induced signal in a manner
similar to the uncleaved isoform. We found that caspase-3
cleavage does not affect its dynamic behaviour or subcellular
localization. Photobleaching revealed that the two apoptotic
fragments move freely and could thus be also engaged in the
regulation of PARG metabolism once they are generated.
PARP-1 and poly(ADP-ribosyl)ation play a prominent role
in cell death in a number of experimental models [55]
suggesting that PARG will be able to relocate to nucleus not
only following γ-irradiation but also in MNNG-induced
toxicity and NMDA excitotoxicity. Given these possibilities,
we assumed that the effect of PARG110 depletion in mice will
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other PARG remains active and can reach the nucleus. Our
results strongly support the idea that residual PARG activity
observed in mice lacking PARG110 is sufficient to hydrolyze
the nuclear PAR and this observation explains why the
disruption of the nuclear PARG110 gene is not lethal for the
mouse [36]. Consistent with an essentially cellular role for
PARG activity, recent findings demonstrated that the complete
knockout of PARG is lethal in mouse. This is because the
uncontrolled PAR accumulation rapidly leads to the induction
of apoptosis in the absence of cellular PARG activity [20,56]. It
is reasonable to expect that the control of PARG activity is
important in several pathological conditions that involve
induction of DNA-strand breaks.Acknowledgements
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